236 related articles for article (PubMed ID: 21603271)
1. The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease.
Koeller CM; Heise N
Enzyme Res; 2011; 2011():648159. PubMed ID: 21603271
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional analysis of Trypanosoma cruzi genes that encode proteins of the glycosylphosphatidylinositol biosynthetic pathway.
Cardoso MS; Junqueira C; Trigueiro RC; Shams-Eldin H; Macedo CS; Araújo PR; Gomes DA; Martinelli PM; Kimmel J; Stahl P; Niehus S; Schwarz RT; Previato JO; Mendonça-Previato L; Gazzinelli RT; Teixeira SM
PLoS Negl Trop Dis; 2013; 7(8):e2369. PubMed ID: 23951384
[TBL] [Abstract][Full Text] [Related]
3. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
4. A novel role of Rab11 in trafficking GPI-anchored trans-sialidase to the plasma membrane of Trypanosoma cruzi.
Niyogi S; Docampo R
Small GTPases; 2015; 6(1):8-10. PubMed ID: 25862161
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi Infection Prevalence and Bloodmeal Analysis in Triatomine Vectors of Chagas Disease From Rural Peridomestic Locations in Texas, 2013-2014.
Gorchakov R; Trosclair LP; Wozniak EJ; Feria PT; Garcia MN; Gunter SM; Murray KO
J Med Entomol; 2016 Jul; 53(4):911-918. PubMed ID: 27106934
[TBL] [Abstract][Full Text] [Related]
6. Inositolphosphoceramide metabolism in Trypanosoma cruzi as compared with other trypanosomatids.
De Lederkremer RM; Agusti R; Docampo R
J Eukaryot Microbiol; 2011; 58(2):79-87. PubMed ID: 21332877
[TBL] [Abstract][Full Text] [Related]
7. Proteins with glycosylphosphatidylinositol (GPI) signal sequences have divergent fates during a GPI deficiency. GPIs are essential for nuclear division in Trypanosoma cruzi.
Garg N; Tarleton RL; Mensa-Wilmot K
J Biol Chem; 1997 May; 272(19):12482-91. PubMed ID: 9139697
[TBL] [Abstract][Full Text] [Related]
8. Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease.
Oliveira MM; Einicker-Lamas M
An Acad Bras Cienc; 2000 Sep; 72(3):413-9. PubMed ID: 11028106
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi surface mucins are involved in the attachment to the Triatoma infestans rectal ampoule.
Cámara MLM; Balouz V; Centeno Cameán C; Cori CR; Kashiwagi GA; Gil SA; Macchiaverna NP; Cardinal MV; Guaimas F; Lobo MM; de Lederkremer RM; Gallo-Rodriguez C; Buscaglia CA
PLoS Negl Trop Dis; 2019 May; 13(5):e0007418. PubMed ID: 31107901
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins from vertebrate host blood plasma are involved in Trypanosoma cruzi epimastigote agglutination and participate in interaction with the vector insect, Rhodnius prolixus.
Moreira CJC; De Cicco NNT; Galdino TS; Feder D; Gonzalez MS; Miguel RB; Coura JR; Castro HC; Azambuja P; Atella GC; Ratcliffe NA; Mello CB
Exp Parasitol; 2018 Dec; 195():24-33. PubMed ID: 30261188
[TBL] [Abstract][Full Text] [Related]
11. Homologous Expression of Glycosylphosphatidylinositol-Anchored Glycoproteins in Trypanosoma cruzi.
Balouz V; Mesias AC; Camean CC; Ducrey I; Lobo MM; Durante IM; Cánepa GE; Buscaglia CA; de Los Milagros Cámara M
Methods Mol Biol; 2019; 1955():119-134. PubMed ID: 30868523
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi, etiological agent of Chagas disease, is virulent to its triatomine vector Rhodnius prolixus in a temperature-dependent manner.
Elliot SL; Rodrigues Jde O; Lorenzo MG; Martins-Filho OA; Guarneri AA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003646. PubMed ID: 25793495
[TBL] [Abstract][Full Text] [Related]
13. Identification of complete precursors for the glycosylphosphatidylinositol protein anchors of Trypanosoma cruzi.
Heise N; Raper J; Buxbaum LU; Peranovich TM; de Almeida ML
J Biol Chem; 1996 Jul; 271(28):16877-87. PubMed ID: 8663209
[TBL] [Abstract][Full Text] [Related]
14. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
Bhatia V; Sinha M; Luxon B; Garg N
Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
[TBL] [Abstract][Full Text] [Related]
15. Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes.
Ropert C; Ferreira LR; Campos MA; Procópio DO; Travassos LR; Ferguson MA; Reis LF; Teixeira MM; Almeida IC; Gazzinelli RT
Microbes Infect; 2002 Jul; 4(9):1015-25. PubMed ID: 12106796
[TBL] [Abstract][Full Text] [Related]
16. Metabolites as predictive biomarkers for
Eberhard FE; Klimpel S; Guarneri AA; Tobias NJ
Comput Struct Biotechnol J; 2021; 19():3051-3057. PubMed ID: 34136103
[No Abstract] [Full Text] [Related]
17. Protozoan Parasites Glycosylphosphatidylinositol Anchors: Structures, Functions and Trends for Drug Discovery.
Morotti ALM; Martins-Teixeira MB; Carvalho I
Curr Med Chem; 2019; 26(23):4301-4322. PubMed ID: 28748758
[TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
[TBL] [Abstract][Full Text] [Related]
19. Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi.
Lederkremer RM; Bertello LE
Curr Pharm Des; 2001 Aug; 7(12):1165-79. PubMed ID: 11472260
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
